Virus-based therapies for colon cancer

Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme

Tumor-targeted gene transfer in vivo via recombinant Newcastle disease virus modified by a bispecific fusion protein

[Study of Newcastle disease virus killing hepatocellular carcinoma cells in vitro]

[Induction of apoptosis in human hepatoma cell line SMMC7721 by Newcastle disease virus HN gene]

Targeting vaccinia to solid tumors with local hyperthermia

T-cell triggering by CD3- and CD28-binding molecules linked to a human virus-modified tumor cell vaccine

Selective gene transfer in vitro to tumor cells via recombinant Newcastle disease virus

Selective gene transfer to tumor cells by recombinant Newcastle Disease Virus via a bispecific fusion protein

Effects of febrile temperature on adenoviral infection and replication: implications for viral therapy of cancer